Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-11

Clinical Trial Update: Donor Stem Cell Transplantation for Congenital Immunodeficiencies [EARLY_Phase 1]

View source ↗

Summary

Early Phase 1 trial of donor stem cell transplantation for inherited immune deficiencies has completed; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Inherited Immune Deficiencies | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2021-05-11